Molecular aspects of antibody mediated T cell activation

<p>The normal physiological activation of naive T cells requires the engagement of both the T cell receptor (TCR) and the co-stimulatory molecule, CD28. However, a group of monoclonal antibodies (mAbs) have been identified that are able to activate T cells <em>in vitro</em> and <...

Full description

Bibliographic Details
Main Author: Morgan, SH
Other Authors: Davis, S
Format: Thesis
Language:English
Published: 2009
Subjects:
_version_ 1817930673164386304
author Morgan, SH
author2 Davis, S
author_facet Davis, S
Morgan, SH
author_sort Morgan, SH
collection OXFORD
description <p>The normal physiological activation of naive T cells requires the engagement of both the T cell receptor (TCR) and the co-stimulatory molecule, CD28. However, a group of monoclonal antibodies (mAbs) have been identified that are able to activate T cells <em>in vitro</em> and <em>in vivo</em> via CD28 engagement alone. Two defining characteristics found in all CD28 superagonist mAbs are their membrane proximal CD28 epitopes and the requirement for mAb immobilisation. To investigate whether agonistic mAbs to similar cell molecules could be identified based on epitope position alone, mAbs to the inhibitory receptor PD-1 were generated and characterised. Using a drastic mutation-based epitope mapping technique, one mAb was identified with a membrane proximal epitope along with two other mAbs with membrane distal epitopes. These mAbs were tested for triggering activity in a hybridoma stimulation assay. mAb stimulation was observed with all three mAbs but only in cells expressing a PD-1 chimera that associated with the TCR and the strength of activation was dependent on epitope location. Cross-linking of a monomeric PD-1/CD28 chimera with a pair of anti-PD-1 mAbs resulted in signalling in this system, however, suggesting a role for ligand aggregation in addition to epitope position in mAb signalling. To further investigate the role of epitope position in CD28 superagonism, a cell line expressing a chimeric form of CD28 was created wherein the superagonistic mAb epitope was moved to a membrane distal position. When stimulated with a CD28 superagonist mAb signalling was no longer observed. However stimulation with another mAb that had an epitope to a membrane proximal location on the chimera resulted in superagonistic effect. These results show that epitope location is the dominant cause of T cell stimulation observed by CD28 superagonist mAbs and that epitope dependent mAb signalling is possible in other T cell surface molecules. The work described in this thesis has implications for both the development of immune modulating mAb therapeutics and for the general mechanism of triggering of cell surface receptors dependent on extrinsic tyrosine kinases.</p>
first_indexed 2024-03-07T01:08:34Z
format Thesis
id oxford-uuid:8c30ca07-b93b-46a7-aa86-01f94ee97e97
institution University of Oxford
language English
last_indexed 2024-12-09T03:09:51Z
publishDate 2009
record_format dspace
spelling oxford-uuid:8c30ca07-b93b-46a7-aa86-01f94ee97e972024-10-02T14:58:58ZMolecular aspects of antibody mediated T cell activationThesishttp://purl.org/coar/resource_type/c_db06uuid:8c30ca07-b93b-46a7-aa86-01f94ee97e97ImmunologyImmunochemistryEnglishOxford University Research Archive - Valet2009Morgan, SHDavis, S<p>The normal physiological activation of naive T cells requires the engagement of both the T cell receptor (TCR) and the co-stimulatory molecule, CD28. However, a group of monoclonal antibodies (mAbs) have been identified that are able to activate T cells <em>in vitro</em> and <em>in vivo</em> via CD28 engagement alone. Two defining characteristics found in all CD28 superagonist mAbs are their membrane proximal CD28 epitopes and the requirement for mAb immobilisation. To investigate whether agonistic mAbs to similar cell molecules could be identified based on epitope position alone, mAbs to the inhibitory receptor PD-1 were generated and characterised. Using a drastic mutation-based epitope mapping technique, one mAb was identified with a membrane proximal epitope along with two other mAbs with membrane distal epitopes. These mAbs were tested for triggering activity in a hybridoma stimulation assay. mAb stimulation was observed with all three mAbs but only in cells expressing a PD-1 chimera that associated with the TCR and the strength of activation was dependent on epitope location. Cross-linking of a monomeric PD-1/CD28 chimera with a pair of anti-PD-1 mAbs resulted in signalling in this system, however, suggesting a role for ligand aggregation in addition to epitope position in mAb signalling. To further investigate the role of epitope position in CD28 superagonism, a cell line expressing a chimeric form of CD28 was created wherein the superagonistic mAb epitope was moved to a membrane distal position. When stimulated with a CD28 superagonist mAb signalling was no longer observed. However stimulation with another mAb that had an epitope to a membrane proximal location on the chimera resulted in superagonistic effect. These results show that epitope location is the dominant cause of T cell stimulation observed by CD28 superagonist mAbs and that epitope dependent mAb signalling is possible in other T cell surface molecules. The work described in this thesis has implications for both the development of immune modulating mAb therapeutics and for the general mechanism of triggering of cell surface receptors dependent on extrinsic tyrosine kinases.</p>
spellingShingle Immunology
Immunochemistry
Morgan, SH
Molecular aspects of antibody mediated T cell activation
title Molecular aspects of antibody mediated T cell activation
title_full Molecular aspects of antibody mediated T cell activation
title_fullStr Molecular aspects of antibody mediated T cell activation
title_full_unstemmed Molecular aspects of antibody mediated T cell activation
title_short Molecular aspects of antibody mediated T cell activation
title_sort molecular aspects of antibody mediated t cell activation
topic Immunology
Immunochemistry
work_keys_str_mv AT morgansh molecularaspectsofantibodymediatedtcellactivation